Routine use of denosumab for prevention of skeletal-related events in patients with bone metastases from prostate carcinoma in Bulgaria: a prospective observational study

Routine use of denosumab for prevention of skeletal-related events in patients with bone metastases from prostate carcinoma in Bulgaria: a prospective observational study

Bulgarian real-world data on denosumab use for the prevention of skeletal-related events (SREs) associated with bone metastases (BM) from prostate cancer (PC) are lacking. This observational study enrolled 100 adult PC patients with ≥1 BM receiving denosumab (EUPAS26983). Patients’ routine treatment...

Full description

Bibliographic Details
Main Authors: Antoaneta Tomova, Valentina Ianakieva, Katja Bjorklof, Adrian Olszewski, Miglena Petrova
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Biotechnology & Biotechnological Equipment
Subjects:
Prostate cancer
bone metastases
skeletal-related events
denosumab
persistence
adherence
Online Access:https://www.tandfonline.com/doi/10.1080/13102818.2024.2366490

Internet

https://www.tandfonline.com/doi/10.1080/13102818.2024.2366490

Similar Items